These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 527220)

  • 1. Increased catecholamine excretion after labetalol therapy: a spurious effect of drug metabolites.
    Miano L; Kolloch R; De Quattro V
    Clin Chim Acta; 1979 Jul; 95(2):211-7. PubMed ID: 527220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Falsely elevated urinary excretion of catecholamines and metanephrines in patients receiving labetalol therapy.
    Feldman JM
    J Clin Pharmacol; 1987 Apr; 27(4):288-92. PubMed ID: 3680586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The urinary excretion of catecholamines and their derivatives in primary hypertension in man.
    Bing RF; Harlow J; Smith AJ; Townshend MM
    Clin Sci Mol Med; 1977 Mar; 52(3):319-23. PubMed ID: 557404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of labetalol on the excretion of catecholamines and their metabolites in primary hypertension].
    Wocial B; Sznajderman M; Brym E; Cybulska I; Czerniewska E
    Pol Tyg Lek; 1981 Aug; 36(35):1337-9. PubMed ID: 7329848
    [No Abstract]   [Full Text] [Related]  

  • 5. [Absence of labetalol interference on urine metanephrine determination in hypertensive patients].
    Girerd X; Billaud EM; Sorrel-Dejerine A; Ropers J; Safavian A; Safar M; Laurent S
    Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1231-4. PubMed ID: 1482264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons from an unpleasant surprise: a biochemical strategy for the diagnosis of pheochromocytoma.
    Gardet V; Gatta B; Simonnet G; Tabarin A; Chêne G; Ducassou D; Corcuff JB
    J Hypertens; 2001 Jun; 19(6):1029-35. PubMed ID: 11403350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary and plasma catecholamines and urinary catecholamine metabolites in pheochromocytoma: diagnostic value in 19 cases.
    Gerlo EA; Sevens C
    Clin Chem; 1994 Feb; 40(2):250-6. PubMed ID: 7906208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnosis of pheochromocytoma. Overnight excretion of catecholamine metabolites.
    Sullivan JM; Solomon HS
    JAMA; 1975 Feb; 231(6):618-9. PubMed ID: 1172846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overnight excretion of urinary catecholamines and metabolites in the detection of pheochromocytoma.
    Peaston RT; Lennard TW; Lai LC
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1378-84. PubMed ID: 8636337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in urinary excretion of catecholamines and their metabolites in pediatric dental patients.
    Sakuma N; Nagasaka N
    ASDC J Dent Child; 1996; 63(2):118-22. PubMed ID: 8708120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Falsely high urinary catecholamines induced by labetalol.
    Kobayashi K; Miura Y; Tomioka H; Sakuma H; Adachi M; Abe K; Yoshinaga K
    Tohoku J Exp Med; 1979 Jan; 127(1):63-9. PubMed ID: 760251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel-Lindau disease and multiple endocrine neoplasia type 2.
    Eisenhofer G; Lenders JW; Linehan WM; Walther MM; Goldstein DS; Keiser HR
    N Engl J Med; 1999 Jun; 340(24):1872-9. PubMed ID: 10369850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Trilostane on urinary Catecholamines and their metabolites in dogs with Hypercortisolism.
    Sieber-Ruckstuhl N; Salesov E; Quante S; Riond B; Rentsch K; Hofmann-Lehmann R; Reusch C; Boretti F
    BMC Vet Res; 2017 Sep; 13(1):279. PubMed ID: 28870207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urinary excretion of catecholamines and their principal metabolites in arterial hypertension].
    Korenev NM; Rasin MS
    Vrach Delo; 1972 Feb; 2():78-81. PubMed ID: 5084752
    [No Abstract]   [Full Text] [Related]  

  • 15. Does labetalol increase excretion of urinary catecholamines?
    Hamilton CA; Jones DH; Dargie HJ; Reid JL
    Br Med J; 1978 Sep; 2(6140):800. PubMed ID: 698739
    [No Abstract]   [Full Text] [Related]  

  • 16. Catecholamine metabolism during heroin use.
    Schildkraut JJ; Meyer RE; Orsulak PJ; Mirin SM; Roffman M; Platz PA; Grab E; Randall ME; McDougle M
    Am J Psychiatry; 1977 May; 134(5):534-7. PubMed ID: 848581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamine metabolism in affective disorders. II. Norepinephrine, normetanephrine, epinephrine, metanephrine, and VMA excretion in hypomanic patients.
    Greenspan K; Schildkraut JJ; Gordon EK; Levy B; Durell J
    Arch Gen Psychiatry; 1969 Dec; 21(6):710-6. PubMed ID: 4901154
    [No Abstract]   [Full Text] [Related]  

  • 18. Positive correlation between urinary excretion of catecholamine metabolites and tumour mass in pheochromocytoma. Results in patients with sustained and paroxysmal hypertension and multiple endocrine neoplasia.
    Stenström G; Waldenström J
    Acta Med Scand; 1985; 217(1):73-7. PubMed ID: 3976435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary excretion of catecholamines and their metabolites in relation to circulating catecholamines. Six-hour infusion of epinephrine and norepinephrine in healthy volunteers.
    Moleman P; Tulen JH; Blankestijn PJ; Man in 't Veld AJ; Boomsma F
    Arch Gen Psychiatry; 1992 Jul; 49(7):568-72. PubMed ID: 1627048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary normetanephrine and metanephrine measured by radioimmunoassay for the diagnosis of pheochromocytoma: utility of 24-hour and random 1-hour urine determinations.
    Oishi S; Sasaki M; Ohno M; Sato T
    J Clin Endocrinol Metab; 1988 Sep; 67(3):614-8. PubMed ID: 3410942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.